4.0 Article

Osteoporosis prescribing trends in primary care: a population-based retrospective cohort study

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

Laura Y. Park-Wyllie et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Endocrinology & Metabolism

Estimating Bisphosphonate Use and Fracture Reduction Among US Women Aged 45 Years and Older, 2001-2008

Ethel S. Siris et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2011)

Article Public, Environmental & Occupational Health

Living with a 'women's disease': risk appraisal and management among men with osteoporosis

Samantha L. Solimeo

JOURNAL OF MENS HEALTH (2011)

Article Geriatrics & Gerontology

Secondary Prevention of Osteoporosis in Australia Analysis of Government-Dispensed Prescription Data

Samantha A. Hollingworth et al.

DRUGS & AGING (2010)

Article Geriatrics & Gerontology

Changing Patterns in Medication Use with Increasing Probability of Death for Older Medicare Beneficiaries

Thomas Shaffer et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)

Article Primary Health Care

Missed opportunities for osteoporosis management in older patients: a literature review

Nishma Manek

Primary Health Care Research and Development (2010)

Article Rheumatology

Osteoporosis in males and females: Is there really a difference?

Pascal Guggenbuhl

JOINT BONE SPINE (2009)

Article Endocrinology & Metabolism

Management of osteoporosis in primary care in Australia

J. S. Chen et al.

OSTEOPOROSIS INTERNATIONAL (2009)

Article Endocrinology & Metabolism

To stop or not to stop, that is the question

Ego Seeman

OSTEOPOROSIS INTERNATIONAL (2009)

Article Endocrinology & Metabolism

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

B. A. Lenart et al.

OSTEOPOROSIS INTERNATIONAL (2009)

Article Medicine, General & Internal

Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture

Suzanne M. Cadarette et al.

ANNALS OF INTERNAL MEDICINE (2008)

Article Endocrinology & Metabolism

Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study

L. Huot et al.

OSTEOPOROSIS INTERNATIONAL (2008)

Article Endocrinology & Metabolism

The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study

A. Papaioannou et al.

OSTEOPOROSIS INTERNATIONAL (2008)

Article Medicine, General & Internal

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

Dennis M. Black et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Endocrinology & Metabolism

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis

CH Chesnut et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2004)

Review Pharmacology & Pharmacy

Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment

WP Olszynski et al.

CLINICAL THERAPEUTICS (2004)

Article Medicine, General & Internal

Effect of risedronate on the risk of hip fracture in elderly women

MR McClung et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Endocrinology & Metabolism

Opinions and experiences in general practice on osteoporosis prevention, diagnosis and management

JC Taylor et al.

OSTEOPOROSIS INTERNATIONAL (2001)

Article Endocrinology & Metabolism

Hip fracture incidence rates in Singapore 1991-1998

LKH Koh et al.

OSTEOPOROSIS INTERNATIONAL (2001)